image_alt_text
7

James Dahlman, Ph.D.

AIMBE College of Fellows Class of 2024
For his use of sophisticated in vivo screens to develop clinically relevant lipid nanoparticles for delivering targeted RNA-based therapies outside the liver.

James Dahlman Inducted into the 2024 Class of the AIMBE College of Fellows

Via AIMBE | March 27, 2024

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of James Dahlman, Ph.D., Associate Professor at Emory University to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”

Professor Dahlman was nominated, reviewed, and elected by peers and members of the College of Fellows “for his use of sophisticated in vivo screens to develop clinically relevant lipid nanoparticles for delivering targeted RNA-based therapies outside the liver…. Continue reading.

...